TerminatedNot Applicable

Early Placental Insufficiency Screening

Stopped: Shortness inclusions of patients

France226 participantsStarted 2007-05

Plain-language summary

To assess the role of uterine artery and maternal serum PlGf and sflt-1 and their combination in screening for pre-eclampsia and small -for-gestational age (SGA) fetuses at 12-14 weeks of gestation

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic hypertension under medication * Insulin or not insulin dependant preexisting diabetes * Previous history of pre-eclampsia * Previous history of unexplained stillbirth * Previous history of placental abruption * Previous history of SGA (\< 10th centile) * History of pre-eclampsia or chronic hypertension before 45 years in the mother or a sister * History of vascular pathology before 50 years in the father * Obesity (BMI\>26) * Nulliparous after 38 years * Assisted conception with donor * Primipaternity after 38 years old or before 20 years old Exclusion Criteria: * Multiple pregnancy * Pregnancy requiring termination * Unability to understand the study * Thrombophilia * treatment with heparin

What they're measuring

Occurrence for Pre-eclampsia or SGA

Timeframe: During pregnancy and until 72h after delivery

Trial details

NCT IDNCT01348711

SponsorUniversity Hospital, Tours

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-02

View on ClinicalTrials.gov More Pre-eclampsia trials